NMI TT Pharmaservices has built up a long-standing expertise in the area of multiplexed immunoassays.

Several technology platforms are available, such that we can provide our clients with validated ready-to-go offerings as well as highly customized services.

Sample types include blood, serum, cultured cells, sections, biopsies and solid tissues.

Applications range from signalling profiling, pathway mapping and lead characterization to biomarker identification and verification, thus covering preclinical and clinical phases of drug development alike.

Project scopes vary from routine screening to assay development and validation studies. 

We offer:
• DigiWest: High Content Protein Profiling
  
• RPPA: Multiplex Sample & Protein Profiling
• Simoa: Ultra-Sensitive Protein Profiling
  
• MS-based TXP Immunoassays
  
• Custom Multiplex Immunoassays
  

Please email us to discuss which platform is most appropriate for your needs, or get in touch with the contact person on the relevant subpage.